Cargando…
Therapeutic Potential of Targeting the SUMO Pathway in Cancer
SIMPLE SUMMARY: The small ubiquitin-like modifier (SUMO) pathway regulates the hallmark properties of cancer cells. Moreover, alterations in activity and in levels of SUMO machinery components have been observed in human cancer. Due to the reversible nature of this post-translational protein modific...
Autores principales: | Kukkula, Antti, Ojala, Veera K., Mendez, Lourdes M., Sistonen, Lea, Elenius, Klaus, Sundvall, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431684/ https://www.ncbi.nlm.nih.gov/pubmed/34503213 http://dx.doi.org/10.3390/cancers13174402 |
Ejemplares similares
-
Genome-wide screen of gamma-secretase–mediated intramembrane cleavage of receptor tyrosine kinases
por: Merilahti, Johannes A. M., et al.
Publicado: (2017) -
Glucocorticoid receptor-induced non-muscle caldesmon regulates metastasis in castration-resistant prostate cancer
por: Virtanen, Verneri, et al.
Publicado: (2023) -
Targeting the SUMO pathway for neuroprotection in brain ischaemia
por: Yang, Wei, et al.
Publicado: (2016) -
SUMO pathway inhibition targets an aggressive pancreatic cancer subtype
por: Biederstädt, Alexander, et al.
Publicado: (2020) -
Targeting the SUMO pathway as a novel treatment for anaplastic thyroid cancer
por: De Andrade, James P., et al.
Publicado: (2017)